Safety and Efficacy of Recombinant Human Bone Morphogenetic Protein 2 on Cranial Defect Closure in the Pediatric Population

被引:15
作者
Beidas, Omar E. [1 ]
Deschamps-Braly, Jordan C. [2 ]
Morgan, Aaron M. [1 ]
Workman, Meredith C. [1 ]
Knotts, Christopher D. [1 ]
Denny, Arlen D. [2 ]
El Amm, Christian A. [1 ]
机构
[1] Univ Oklahoma, Div Plast Surg, Dept Surg, Coll Med, Oklahoma City, OK 73104 USA
[2] Med Coll Wisconsin, Childrens Hosp Wisconsin, Milwaukee, WI 53226 USA
关键词
BMP-2; bone graft; cranial defect; craniofacial; cranioplasty; rhBMP-2; exchange cranioplasty; particulate cranioplasty; CALVARIAL DEFECTS; TIBIAL FRACTURES; DURA-MATER; RECONSTRUCTION; FUSION; EXPRESSION; SURGERY; REPAIR; COMPLICATIONS; OSTEOGENESIS;
D O I
10.1097/SCS.0b013e318256657c
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Traditional reconstructive options for cranial defects include autogenous bone graft, bone substitutes, and synthetic materials. The established standard for repairing cranial defects is autogenous bone. However, young children do not have abundant donor sites for bone harvest, which leads to challenges in closing calvarial defects. Synthetic materials are not ideal alternatives because they require subsequent retrieval and are prone to infection. Their long-term effects on growth of the skull are also not well studied. Bone morphogenetic protein 2 (BMP-2), are shown to positively affect closure of cranial defects in animal models. We present a study comparing the efficacy and safety of closure of cranial defect with bone graft augmented with recombinant human BMP-2 (rhBMP-2) and compared with a series of patients treated with bone graft alone. Methods: This study is a retrospective multicenter evaluation of 36 patients spanning 5 years. Twenty-one patients undergoing cranial defect closure augmented with rhBMP-2 were compared with 15 patients who underwent cranial defect closure using cranial bone shavings alone. We measured preoperative and postoperative defect size on volumetric computed tomographic scan reconstructions to compare defect sizes. Results: The rhBMP-2 group had slightly increased proportional closure compared with the control group, 86% versus 76%(P<0.018), respectively. Two patients in the rhBMP-2 group had postoperative fusion of a suture that was known to be patent at the time of cranial defect closure. No instances of brain edema, herniation, airway compromise, or other adverse effects directly attributable to rhBMP-2 were observed. Conclusions: Bone morphogenetic protein 2 may increase the amplitude and uptake of cranial bone grafts in cranial defect closure. This study shows that defect sizes of up to 16 cm(2) can be reliably closed using this technique. Postoperative fusion of uninvolved sutures in 2 patients indicates that rhBMP-2 may have unreported adverse effects; consideration of this finding should be weighed against the benefit of improved closure of calvarial defects.
引用
收藏
页码:917 / 922
页数:6
相关论文
共 51 条
[1]   Three-dimensional technology and bone morphogenetic protein in frontal bone reconstruction [J].
Arnander, C ;
Westermark, A ;
Veltheim, R ;
Docherty-Skogh, AC ;
Hilborn, J ;
Engstrand, T .
JOURNAL OF CRANIOFACIAL SURGERY, 2006, 17 (02) :275-279
[2]   A prospective, randomized, controlled cervical fusion study using recombinant human bone morphogenetic protein-2 with the CORNERSTONE-SR™ allograft ring and the ATLANTIS™ anterior cervical plate [J].
Baskin, DS ;
Ryan, P ;
Sonntag, V ;
Westmark, R ;
Widmayer, MA .
SPINE, 2003, 28 (12) :1219-1224
[3]   De novo bone induction by recombinant human bone morphogenetic protein-2 (rhBMP-2) in maxillary sinus floor augmentation [J].
Boyne, PJ ;
Lilly, LC ;
Marx, RE ;
Moy, PK ;
Nevins, M ;
Spagnoli, DB ;
Triplett, RG .
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2005, 63 (12) :1693-1707
[4]  
BRADLEY J, 2007, INT SOC CRAN SURG BI
[5]  
CARSTENS M, 2007, INT SOC CRAN SURG BI
[6]   Bone morphogenetic proteins [J].
Chen, D ;
Zhao, M ;
Mundy, GR .
GROWTH FACTORS, 2004, 22 (04) :233-241
[7]   Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs) [J].
Cheng, HW ;
Jiang, W ;
Phillips, FM ;
Haydon, RC ;
Peng, Y ;
Zhou, L ;
Luu, HH ;
An, NL ;
Breyer, B ;
Vanichakarn, P ;
Szatkowski, JP ;
Park, JY ;
He, TC .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2003, 85A (08) :1544-1552
[8]   Biomaterials in craniofacial reconstruction [J].
Cho, YR ;
Gosain, AK .
CLINICS IN PLASTIC SURGERY, 2004, 31 (03) :377-+
[9]   Molecular control of neural crest formation, migration and differentiation [J].
Christiansen, JH ;
Goles, EG ;
Wilkinson, DG .
CURRENT OPINION IN CELL BIOLOGY, 2000, 12 (06) :719-724
[10]   Closure of critical sized defects with allogenic and alloplastic bone substitutes [J].
Clokie, CML ;
Moghadam, H ;
Jackson, MT ;
Sandor, GKB .
JOURNAL OF CRANIOFACIAL SURGERY, 2002, 13 (01) :111-121